Immune Privilege and Eye-Derived T-Regulatory Cells.

Area of Science:

• Ophthalmology
• Immunology
• Cell Biology

Background:

• The eye possesses unique immune privilege to protect vision from inflammation.
• Neural retina and other ocular components lack regenerative capacity after inflammation.
• Ocular immune privilege involves immune ignorance, peripheral tolerance, and an immunosuppressive microenvironment.

Purpose of the Study:

• To review the molecular mechanisms maintaining ocular immune privilege.
• To explore the role of regulatory T cells (Tregs) in ocular immune privilege.
• To examine therapeutic strategies involving Tregs for ocular autoimmune diseases.

Main Methods:

• Review of current literature on ocular immune privilege and Tregs.
• Analysis of molecular mechanisms involving anterior chamber-associated immune deviation (ACAID).
• Evaluation of therapeutic potential of RPE-induced Tregs for autoimmune uveoretinitis.

Main Results:

• Regulatory T cells (Tregs) are crucial for maintaining ocular immune privilege.
• Ocular resident cells like corneal endothelial (CE) and retinal pigment epithelial (RPE) cells contribute to Treg generation.
• RPE cells expressing TGF-β, CTLA-2α, and retinoic acid can generate therapeutic Tregs.

Conclusions:

• A deeper understanding of ocular immune privilege and Tregs is essential.
• Treg-based therapies hold promise for treating inflammatory and autoimmune ocular conditions.
• Harnessing human RPE-induced Tregs presents a novel clinical strategy for ocular inflammatory diseases.